Related Experiment Videos
Identification of a human NF-kappaB-activating protein, TAB3.
Ge Jin1, Alison Klika, Michelle Callahan
1Athersys, Inc., 3201 Carnegie Avenue, Cleveland, OH 44115, USA.
Summary
Researchers identified TAB3 as a novel regulator of the nuclear factor kappa B (NF-kappaB) pathway. Overexpression of TAB3 activates NF-kappaB, promotes cell transformation, and is linked to cancer development.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The NF-kappaB pathway is crucial for cellular functions like immune response and apoptosis.
- Dysregulation of NF-kappaB is implicated in various cancers and immune disorders.
Purpose of the Study:
- To identify novel positive regulators of the NF-kappaB pathway using a reporter cell line.
- To investigate the role of a newly identified gene, TAB3, in NF-kappaB signaling and oncogenesis.
Main Methods:
- Utilized Random Activation of Gene Expression technology for screening.
- Generated and screened a protein expression library for constitutive NF-kappaB activation.
- Validated TAB3 function through overexpression studies and inhibitor assays.
Main Results:
- Identified human TAB3 as a novel component of the NF-kappaB pathway.
- Demonstrated that TAB3 activates both NF-kappaB and AP-1 transcription factors.
- Showed that TAB3 functions upstream of TAK1-binding protein 3 and tumor necrosis factor alpha-associated factor 6.
- Observed increased TAB3 expression in some cancers and its role in cellular transformation.
Conclusions:
- TAB3 is a novel positive regulator of the NF-kappaB pathway.
- Elevated TAB3 expression contributes to constitutive NF-kappaB activation and oncogenesis.
- TAB3 represents a potential therapeutic target in cancer treatment.